$TRS

TRIMAS CORP

1
0
0

No SEC Form 4 filings for $TRS in the last 30 days.

Med

TriMas (TRS) Q2 2026 Earnings Call Transcript

TriMas (TRS) reported Q2 2026 net sales of $174.6M, up 1.6% YoY, with organic sales essentially flat. Adjusted operating profit rose 29% to $14.9M and adjusted EPS was $0.52. Management raised 2026 guidance to $1.60-$1.70 adjusted EPS and expects margin improvement, citing cost actions and interest income. Cash was $1.2B and net cash $846M after the Aerospace divestiture.

TriMas (TRS) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 10:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations and Communications - Sherry Lauderback President and Chief Executive Officer - Thomas J. Snyder Chief Financial Officer - Paul A. Swart TAKEAWAYS Net Sales -- $174.6 million for the second quarter, representing a 1.6% increase year over year driven by favorable foreign currency translation.

TRS sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning TRS (TRIMAS CORP). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent TRS coverage spans earnings, financial news and market movers.

What's driving TRS

  • Guidance raise plus expected Q3 margin expansion creates a near-term earnings revision tailwind, but resin-cost under-recovery and staffing ramp issues remain key swing factors.

    fool.com · Aug 4, 2026

  • Fresh reiterations of bullish analyst views may support the stock, but they are not a new operational disclosure.

    theglobeandmail.com · Aug 1, 2026

  • Guidance raise plus expected Q3 margin expansion creates a near-term re-rating setup, but resin-cost under-recovery and staffing ramp issues remain key swing factors.

    fool.com · Jul 31, 2026

  • Guidance raise plus margin expansion outlook should support near-term sentiment, but execution risks remain around resin cost recovery and facility consolidation.

    yahoo.com · Jul 30, 2026

  • Guidance raise and strong profitability/cost-out progress are likely to support near-term sentiment, while cash burn and FCF timing remain watch items.

    SEC EDGAR 8-K · Jul 30, 2026

alphai scores every news story that mentions TRS with an AI model for sentiment and relevance, and aggregates insider trades from TRIMAS CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $TRS

Score
$TRSMedAI 8/10

TriMas (TRS) Q2 2026 Earnings Call Transcript

TriMas (TRS) reported Q2 2026 net sales of $174.6M, up 1.6% YoY, with organic sales essentially flat. Adjusted operating profit rose 29% to $14.9M and adjusted EPS was $0.52. Management raised 2026 guidance to $1.60-$1.70 adjusted EPS and expects margin improvement, citing cost actions and interest income. Cash was $1.2B and net cash $846M after the Aerospace divestiture.

$TRSMedAI 8/10

TriMas (TRS) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 10:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations and Communications - Sherry Lauderback President and Chief Executive Officer - Thomas J. Snyder Chief Financial Officer - Paul A. Swart TAKEAWAYS Net Sales -- $174.6 million for the second quarter, representing a 1.6% increase year over year driven by favorable foreign currency translation.

$TRSMed

TriMas Corporation Q2 2026 Earnings Call Summary

TriMas held its Q2 2026 earnings call after divesting its Aerospace segment. Management said organic sales were flat as industrial and life sciences growth was offset by consumer pressure and macro uncertainty. Profit improved mainly from a $10.5M cost-reduction program. Full-year 2026 guidance: sales growth 3% to 6%, operating margin up 300+ bps, adjusted EPS $1.60-$1.70.

$TRSMed

TRIMAS CORP (TRS): Results of Operations and Financial Condition

TRIMAS CORP (TRS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 trs_06302026xexhibit991.htm EX-99.1 Document TRIMAS REPORTS SECOND QUARTER 2026 RESULTS Raises Low End and Midpoint of Full Year 2026 EPS Outlook • Second quarter operating profit increased to $10.9 million, while adjusted operating profit increased 29.1% to $14.9 milli

Earnings call transcript: TriMas Q1 2026 beats EPS and revenue forecasts

TriMas Corporation reported strong first-quarter 2026 results, surpassing EPS and revenue forecasts with $0.24 EPS and $168.28 million in revenue. The company's stock rose 3.05% in pre-market trading, driven by organic growth, operational improvements, and strategic divestitures. TriMas also reaffirmed its full-year 2026 guidance, expecting continued sales growth and significant operating margin expansion.

$TRSHigh

TriMas (NASDAQ:TRS) Rating Lowered to "Strong Sell" at Zacks Research

Zacks Research downgraded TriMas (NASDAQ:TRS) from a "hold" to a "strong sell" rating. This follows a mixed performance from other analysts, with a consensus "Hold" rating and an average target price of $41.50. TriMas recently missed quarterly earnings estimates, reporting $0.40 EPS against $0.41 expected, and revenue of $155.49 million, below analyst estimates of $192.96 million.

$TRSLow

Zacks Research Downgrades TriMas (NASDAQ:TRS) to Hold

Zacks Research has downgraded TriMas (NASDAQ:TRS) from a "strong-buy" to a "hold" rating, reflecting mixed analyst opinions with a consensus of "Moderate Buy" and an average price target of $41.50. Despite the downgrade, TriMas recently surpassed quarterly earnings and revenue estimates and provided positive FY2025 guidance. Insider activity shows a director purchasing 2,000 shares, and institutional ownership remains very high at 99.42%.

Related tickers